Total Payments
$3,359
2024 Payments
$1,429
Companies
12
Transactions
171
Medicare Patients
247
Medicare Billing
$7,986
Payment Breakdown by Category
Food & Beverage$3,208 (95.5%)
Education$150.63 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,208 | 168 | 95.5% |
| Education | $150.63 | 3 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $941.47 | 81 | $0 (2024) |
| Indivior Inc. | $562.01 | 26 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $491.17 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $481.52 | 18 | $0 (2024) |
| Alkermes, Inc. | $319.61 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $168.31 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $139.46 | 6 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $137.31 | 2 | $0 (2024) |
| ITI, Inc. | $66.98 | 3 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.31 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,429 | 53 | ABBVIE INC. ($319.72) |
| 2023 | $832.35 | 45 | Indivior Inc. ($260.65) |
| 2022 | $613.32 | 36 | Indivior Inc. ($156.98) |
| 2021 | $484.14 | 37 | AbbVie Inc. ($246.99) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $121.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: CNS | ||||||
| 11/14/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: CNS | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $117.33 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $119.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: CNS | ||||||
| 11/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: CNS | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $71.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CNS | ||||||
| 10/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: CNS | ||||||
| 09/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $125.44 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 81 | 119 | $9,119 | $2,174 |
| 2022 | 1 | 39 | 59 | $4,371 | $1,401 |
| 2021 | 1 | 44 | 68 | $5,038 | $2,001 |
| 2020 | 1 | 83 | 106 | $7,854 | $2,410 |
Total Patients
247
Total Services
352
Medicare Billing
$7,986
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 39 | 63 | $4,631 | $1,472 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 16 | $2,710 | $503.12 | 18.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Facility | 2023 | 27 | 40 | $1,778 | $198.80 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 39 | 59 | $4,371 | $1,401 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 44 | 68 | $5,038 | $2,001 | 39.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 44 | 55 | $4,075 | $1,249 | 30.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 51 | $3,779 | $1,160 | 30.7% |
About Lesa Beach, NP
Lesa Beach, NP is a Family healthcare provider based in Albany, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1831442888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lesa Beach, NP has received a total of $3,359 in payments from pharmaceutical and medical device companies, with $1,429 received in 2024. These payments were reported across 171 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,208).
As a Medicare-enrolled provider, Beach has provided services to 247 Medicare beneficiaries, totaling 352 services with total Medicare billing of $7,986. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Albany, GA
- Active Since 10/16/2012
- Last Updated 10/16/2012
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1831442888
Products in Payments
- VRAYLAR (Drug) $870.14
- PERSERIS (Drug) $542.81
- INVEGA SUSTENNA (Drug) $481.52
- UZEDY (Drug) $187.74
- LYBALVI (Drug) $167.17
- ARISTADA (Drug) $152.44
- COBENFY (Drug) $148.87
- FANAPT (Drug) $137.31
- Austedo XR (Drug) $104.00
- CAPLYTA (Drug) $86.29
- REXULTI (Drug) $77.23
- UBRELVY (Drug) $71.33
- AUSTEDO (Drug) $50.26
- ABILIFY MAINTENA (Drug) $46.62
- SUBLOCADE (Drug) $19.20
- LATUDA (Drug) $16.54
- ABILIFY ASIMTUFII (Drug) $15.61
- INGREZZA (Drug) $15.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Albany
Lisa Armao, Anp, ANP
Family — Payments: $61,953
Family $61,953
Yvonne Fuller-Fontenot, F.n.p, F.N.P
Family — Payments: $48,800
Family $48,800
Elvira Faw, Np, NP
Family — Payments: $12,359
Family $12,359
Rodney Siau, Fnp-C, FNP-C
Family — Payments: $11,071
Family $11,071
Mrs. Jennifer Berry, Np, NP
Family — Payments: $8,911
Family $8,911
Melissa Stevenson
Family — Payments: $7,718
Family $7,718